Bank of New York Mellon’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
458,659
+5,239
| +1% | +$12.1K | ﹤0.01% | 3083 |
|
|
2025
Q1 | $630K | Buy |
453,420
+3,159
| +0.7% | +$4.39K | ﹤0.01% | 3319 |
|
|
2024
Q4 | $779K | Buy |
450,261
+111,989
| +33% | +$194K | ﹤0.01% | 3273 |
|
|
2024
Q3 | $680K | Sell |
338,272
-116,192
| -26% | -$234K | ﹤0.01% | 3335 |
|
|
2024
Q2 | $1.02M | Buy |
+454,464
| New | +$1.02M | ﹤0.01% | 3187 |
|
|
2024
Q1 | – | Sell |
-58,140
| Closed | -$103K | – | 4304 |
|
|
2023
Q4 | $103K | Buy |
58,140
+32,066
| +123% | +$56.8K | ﹤0.01% | 4071 |
|
|
2023
Q3 | $82.4K | Buy |
+26,074
| New | +$82.4K | ﹤0.01% | 4097 |
|
|
2022
Q4 | – | Sell |
-11,295
| Closed | -$22K | – | 4550 |
|
|
2022
Q3 | $22K | Sell |
11,295
-375
| -3% | -$730 | ﹤0.01% | 4443 |
|
|
2022
Q2 | $44K | Sell |
11,670
-66,567
| -85% | -$251K | ﹤0.01% | 4375 |
|
|
2022
Q1 | $510K | Buy |
78,237
+2,067
| +3% | +$13.5K | ﹤0.01% | 3698 |
|
|
2021
Q4 | $887K | Buy |
76,170
+2,425
| +3% | +$28.2K | ﹤0.01% | 3447 |
|
|
2021
Q3 | $1.37M | Buy |
73,745
+17,073
| +30% | +$318K | ﹤0.01% | 3215 |
|
|
2021
Q2 | $1.2M | Buy |
56,672
+29,740
| +110% | +$631K | ﹤0.01% | 3294 |
|
|
2021
Q1 | $546K | Sell |
26,932
-48
| -0.2% | -$973 | ﹤0.01% | 3642 |
|
|
2020
Q4 | $716K | Buy |
+26,980
| New | +$716K | ﹤0.01% | 3445 |
|